Theragen Bio provides genome service to more than 700 domestic medical and research institutes over 40 countries abroad, being as a global genome service provider and AI-based biopharmaceutical company specializing in the development of the fourth-generation personalized anti-cancer drugs. Theragen Bio strives to realize precision medicine based on genomic technology, thereby providing the true hope and practical solutions for welfare and health of mankind.

Based on the DeepOmics™ platform developed as a global genomic data-based AI algorithm capability, we are developing systematic new antigen vaccines and anticancer drugs. After recruiting professor Paik Soon-myung, the head of Yonsei Medical Research Center, as Chief Technology Officer, we are expanding our R&D area further and aim to enter clinical trials for rectal cancer treatments and neo-antigen vaccines within 2-3 years.

We are hiring passionate and talented candidates who will fulfill their dreams and future 365 days a year.

If you apply through "Careers- Online Application," we will review it within a week and reply kindly.